Reemergence of monkeypox: prevention and management

Expert Rev Anti Infect Ther. 2022 Nov;20(11):1425-1433. doi: 10.1080/14787210.2022.2128763. Epub 2022 Sep 30.

Abstract

Introduction: The reemergence of monkeypox virus in the twenty-first century, calls for an urgency in its control and preventive measures. There is a long-standing concern that the reemergence of monkeypox across countries could lead to another epidemic like the COVID-19 pandemic. Understanding the disease ecology, preventing its transmission could help curbing its spread. The established treatment protocols along with development of new antiviral agents and vaccines could play a pivotal role in controlling its transmission.

Areas covered: In this review, we summarize the different modes of transmission of this disease, the associated symptoms, the standard protocol of treatment, the available vaccines and use of alternative treatments. We have collated recent research on novel entities that could potentially treat monkeypox infection.

Expert opinion: The One Health approach fostered by the World Health Organization (WHO) for emergent and reemerging zoonotic diseases has to be implemented with a view to curb their transmission. The growing global population and increased inter-country travel has led to rapid spread of transmissible pathogens. Stigmatization, associated with lack of knowledge can be prevented by enhancing awareness campaigns. Vaccines need to be administered to high-risk individuals, and drug discovery efforts need to be intensified to combat such diseases.

Keywords: Monkeypox; antibodies; antiviral agents; herbs; therapeutics; vaccines.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19* / prevention & control
  • Humans
  • Monkeypox virus
  • Mpox (monkeypox)* / drug therapy
  • Mpox (monkeypox)* / epidemiology
  • Mpox (monkeypox)* / prevention & control
  • Pandemics

Substances

  • Antiviral Agents